参考文献/References:
[1] Matthews KA,Sowers MF,Derby CA,et al.Ethnic differences in cardiovascular risk factor burden among middle-aged women:study of women's health across the nation(SWAN)[J].Am Heart J,2005,149(6):1066-1073.
[2] Ushioda M,Makita K,Takamatsu K,et al.Serum lipoprotein(a)dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a)levels in middle-aged and older Japanese women[J].Horm Metab Res,2006,38(9):581-586.
[3] Espeland MA,Marcovina SM,Miller V,et al.Effect of postmenopausal hormone therapy on lipoprotein(a)concentration PEPI investigators.Postmenopausal estrogen/progestin interventions[J].Circulation,1998,97(10):979-986.
[4] Boffelli D,Zajchciwski DA,Yang Z,et al.Estrogen modulation of apolipoprotein(a)expression.Identification of a regulatory element[J].J Biol Chem,1999,274(22):15569-15574.
[5] Pang RW,Lam KS.Hormonal influences on lipoprotein(a)metabolism[J].Diabetes Obesity Meta,2002,4(3):156-165.
[6] 布庆侠,徐 军.老年男性急性脑梗死患者血Lp(a)与性激素的相关性[J].实用老年杂志,2007,21(2):99-100.
Bu QX,Xu J.Study on correlation between lipoprotein(a)and sex hormone in elderly male patients with acute cerebral infarction[J].Pract Geriatr,2007,21(2):99-100,
[7] 钟 堃,王 薇,何法霖,等.国内临床化学9项常规项目参考区间与即将发布的卫生行业标准的比较和分析[J].现代检验医学杂志,2015,30(3):38-42.
Zhong K,Wang W,He FL,et al.Comparison and analysis of the reference intervals of 9 serum routine chemical analytes between the current application of clinical laboratories and the latest health industrial standards draft forapproval[J].J Mod Lab Med,2015,30(3):38-42.
[8] 陈伟伟,高润霖,刘力生.中国心血管病报告2013概要[J].中国循环杂志,2014,29(7):487-491.
Chen WW,Gao RL,Liu LS.2013 report on cardiovascular diseases in China[J].Chinese Circulation Journal,2014,29(7):487-491.
[9] Emerging Risk Factors Collaboration,Ergou S,Kaptoge S,et al.Lipoprtein(a)concentration and the risk of coronary heart disease,stroke,and nonvascular mortality[J].JAMA,2009,302(4):412-423.
[10] GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortalityfor 240 causes of death,1990-2013:a systematic analysis for the Global Burdenof Disease Study 2013[J].Lancet,2015,385(9963):117-171.
[11] Catapano AL,Reiner Z,De Backer G,et al.ESC/EAS Guidelines for themanagement of dyslipidaemias the task force for the management of dyslipidaemiasof the European Society of Cardiology(ESC)and the European Atheroselerosis Society(EAS)[J].Atherosclerosis,2011,217(1):3-46.
相似文献/References:
[1]周晓艳,李 越,何 谦,等.不同基因型HCV感染患者血清Lpa水平检测分析[J].现代检验医学杂志,2018,33(01):49.[doi:10.3969/j.issn.1671-7414.2018.01.001]
ZHOU Xiao-yan,LI Yue,HE Qian,et al.Analysis of Serum Lp(a)Levels in Patients
with Different Genotypes of HCV Infection[J].Journal of Modern Laboratory Medicine,2018,33(01):49.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[2]李 芳,冉向阳,李 玮,等.缺血性脑卒中患者血清GR,SOD,Cys-C,Hcy和Lp(a)水平对预后的预警价值研究[J].现代检验医学杂志,2025,40(02):92.[doi:10.3969/j.issn.1671-7414.2025.02.017]
LI Fang,RAN Xiangyang,LI Wei,et al.Study on the Prognostic Warning Value of Serum GR, SOD, Cys-C, Hcy and Lp(a) Levels in Patients with Cerebral Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2025,40(01):92.[doi:10.3969/j.issn.1671-7414.2025.02.017]